Register | Login

Trial that compared initial treatment together with the combination of leucovorin, 5-FU, and irinotecan (FOLFIRI) for the exact same therapy with cetuximab, there was a significant interaction among KRAS mutation status and survival outcome (9). Quite a few other equivalent studies and also a meta-analysis came to similar conclusions (12,39-41). Thus, KRAS mutation testing has been integrated into

Who Voted for this Story


Instant Approval Social Bookmarking Websites

Pligg is an open source content management system that lets you easily create your own social network.